The Latest Research for NAFLD!

The Latest Research for NAFLD!

November 29, 2021 0
ALH_Facebook_NAFLD_17NOV2021_RD-1.jpg

In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical research. NAFLD has emerged as the most prominent cause of chronic liver disease. So what’s new in NAFLD research? Let’s find out!

PUBLIC SERVICE ANNOUNCEMENT!

NAFLD researchers are urging the public to take care of themselves by declaring NAFLD as a public health priority. They are realizing that the general public does not possess proper knowledge of NAFLD and they desire to change that. At the Digital NAFLD Summit 2021, researchers developed a final set of 37 consensus statements and 26 recommendations. The statements addressed a broad range of topics relevant to policymakers, practitioners, civil society groups, researchers, and affected populations. They hope that these recommendations can bring major change to NAFLD basic knowledge and prevention.

30% of adults have fatty liver

Who Has a Higher Risk of Getting NAFLD?

Anyone can develop NAFLD. Unfortunately, we don’t know everything about this condition. However, clinical research has provided a lot of information about who can get it or what causes fatty liver. We do know that it is more common for people that have the following factors:

  • Type 2 diabetes and prediabetes
  • Obesity
  • Middle-aged or older
  • Hispanic
  • High levels of fats in the blood
  • High blood pressure
  • Take certain drugs
  • Have certain metabolic disorders
  • Experienced rapid weight loss
  • Have certain infections, such as hepatitis C
  • Were exposed to toxins

NAFLD Treatment and Prevention

There is no medication or vaccine approved by the FDA to treat NAFLD. Fortunately, there are ways in which you can reduce or prevent fatty liver. Common suggestions from physicians include:

  • Losing weight
  • Get regular exercise
  • Eating a healthy diet that reduces salt and sugar intake
  • Get vaccinated for hepatitis A and B, the flu, and pneumococcal disease

NAFLD clinical research is so crucial today. We need clinical trials to develop treatments for NAFLD and you can help us. Participate in clinical trials to help the advancement in medicine for NAFLD. You can sign up for our current or upcoming studies by calling us at (480) 360-4000 or visiting our website.

Sources:

https://www.healio.com/news/hepatology/20210924/six-recent-reports-from-the-digital-nafld-summit-2021

https://www.healio.com/news/hepatology/20210917/researchers-deem-nafld-a-public-health-priority

https://easl.eu/press-release/treatment-advances-for-non-alcoholic-fatty-liver-disease-nafld-announced-at-ilc-2021/

https://atriumhealth.org/about-us/newsroom/news/2021/04/groundbreaking-clinical-trials-for-patients-with-nonalcoholic-fatty-liver-disease

https://medlineplus.gov/fattyliverdisease.html


Leave a Reply

Your email address will not be published. Required fields are marked *



Social networks


Facebook

www.facebook.com/azclinicaltrials


Twitter

@azclintrials


Instagram

@azclinicaltrials



Locations


Mesa Office

2152 S Vineyard Ave Ste 123
Mesa, AZ 85210
480-360-4000


Tucson Office

1601 N Swan Rd
Tucson, AZ 85712
520-445-4000


Call us to see if you or your patient qualify for a clinical trial.